January 22, 2019
Gilead Sciences to Release Fourth Quarter and Full Year 2018 Financial Results on Monday, February 4, 2019
-- Conference Call and Webcast to Follow --
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan. 22, 2019--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth
quarter and full year 2018 financial results will be released on Monday,
February 4, after the market closes. At 4:30 p.m. Eastern Time, Gilead’s
management will host a conference call to discuss the company’s
financial results for the fourth quarter and full year 2018 and provide
a business update.
The live webcast of the call can be accessed at the company’s Investors
page at http://investors.gilead.com/.
Please connect to the company’s website at least 15 minutes prior to the
start of the call to ensure adequate time for any software download that
may be required to listen to the webcast. Alternatively, please call
877-359-9508 (U.S.) or 224-357-2393 (international) and dial the
conference ID 3826138 to access the call. Telephone replay will be
available approximately two hours after the call through 8:00 p.m.
Eastern Time, February 6, 2019. To access the replay, please call
855-859-2056 (U.S.) or 404-537-3406 (international) and dial the
conference ID 3826138. The webcast will be archived on www.gilead.com
for one year.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that
discovers, develops and commercializes innovative medicines in areas of
unmet medical need. The company strives to transform and simplify care
for people with life-threatening illnesses around the world. Gilead has
operations in more than 35 countries worldwide, with headquarters in
Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190122005843/en/
Source: Gilead Sciences, Inc.